Cytokinetics, Incorporated (CYTK)

NASDAQ: CYTK · Real-Time Price · USD

76.76

-0.05 (-0.07%)

At close: May 29, 2026, 4:00 PM EDT

76.00

-0.76 (-0.99%)

After-hours: May 29, 2026, 7:44 PM EDT

Cytokinetics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	105.82	88.04	18.47	7.53	94.59	70.43
Revenue Growth (YoY)	450.60%	376.56%	145.34%	-92.04%	34.30%	26.15%
Cost of Revenue	411.71	416.03	339.41	330.12	240.81	159.94
Gross Profit	-305.9	-327.99	-320.93	-322.59	-146.23	-89.51
Selling, General & Admin	331.8	284.27	215.31	173.61	177.98	96.8
Research & Development	411.71	416.03	339.41	330.12	240.81	159.94
Total Operating Expenses	743.51	700.3	554.72	503.74	418.79	256.74
Operating Income	-640.25	-612.26	-536.25	-496.21	-324.2	-186.31
Interest Income	45.74	48.42	51.53	27.63	11.34	0.33
Interest Expense	-114.26	-103.87	-86.51	-57.67	-76.1	-29.33
Other Non-Operating Income (Expense)	-120.85	-117.25	-18.3	-	-	-
Total Non-Operating Income (Expense)	-189.37	-172.7	-53.28	-30.04	-64.75	-29
Pretax Income	-829.61	-784.96	-589.53	-526.24	-388.96	-215.31
Net Income	-829.61	-784.96	-589.53	-526.24	-388.96	-215.31
Net Income to Common	-829.61	-784.96	-589.53	-526.24	-388.96	-215.31
Shares Outstanding (Basic)	121	120	112	97	90	77
Shares Outstanding (Diluted)	121	120	112	97	90	77
Shares Change (YoY)	4.67%	7.26%	16.01%	7.46%	16.83%	19.16%
EPS (Basic)	-6.84	-6.54	-5.26	-5.45	-4.33	-2.80
EPS (Diluted)	-6.84	-6.54	-5.26	-5.45	-4.33	-2.80
Shares Outstanding	123.27	122.94	118.21	101.64	94.83	84.8
Free Cash Flow	-548.92	-534.82	-399.8	-415.75	-310.85	-191.39
Free Cash Flow Per Share	-4.53	-4.45	-3.57	-4.31	-3.46	-2.49
Gross Margin	-289.08%	-372.55%	-1737.22%	-4284.10%	-154.59%	-127.09%
Operating Margin	-605.06%	-695.44%	-2902.72%	-6589.71%	-342.75%	-264.54%
Profit Margin	-784.02%	-891.60%	-3191.11%	-6988.63%	-411.21%	-305.72%
FCF Margin	-518.76%	-607.48%	-2164.10%	-5521.24%	-328.64%	-271.76%
EBITDA	-629.04	-602.13	-526.72	-484.31	-318.39	-184.04
EBITDA Margin	-594.47%	-683.94%	-2851.13%	-6431.78%	-336.61%	-261.31%
EBIT	-640.25	-612.26	-536.25	-496.21	-324.2	-186.31
EBIT Margin	-605.06%	-695.44%	-2902.72%	-6589.71%	-342.75%	-264.54%

SEC Filings: 10-K · 10-Q